390 related articles for article (PubMed ID: 19893359)
1. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
Wiita AP; Nambiar A
Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
4. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
6. The use of a potential novel tool in virtual crossmatching for platelet transfusion in platelet refractoriness.
Bub CB; Gonçalez AC; Barjas-Castro ML; Sousa LC; do Monte SJ; Castro V
Vox Sang; 2016 Jan; 110(1):70-8. PubMed ID: 26274830
[TBL] [Abstract][Full Text] [Related]
7. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
[TBL] [Abstract][Full Text] [Related]
8. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
9. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
10. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
11. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
[TBL] [Abstract][Full Text] [Related]
12. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
Yam P; Petz LD; Scott EP; Santos S
Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
[TBL] [Abstract][Full Text] [Related]
13. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
15. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Gelb AB; Leavitt AD
Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
17. The alloimmunized patient: effective transfusion support and newer experimental approaches.
Pamphilon DH
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334
[TBL] [Abstract][Full Text] [Related]
18. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
[TBL] [Abstract][Full Text] [Related]
20. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Elhence P; Chaudhary RK; Nityanand S
Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
